We have recently shown that the Alzheimer’s disease (AD) therapeutic drug donepezil activates the Rac1-PAK pathway in the nucleus accumbens (NAc) for enhanced aversive learning. The gene discussed is RAC1; the disease is early-onset autosomal dominant Alzheimer disease.